Literature DB >> 22869871

Cutaneous manifestations of unspecified peripheral T-cell lymphoma may be indicative of disease activity and predict response to therapy.

Michael K Schowalter1, Oleg E Akilov, Sara K Story, Larisa J Geskin.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22869871      PMCID： PMC3675668          DOI： 10.1200/JCO.2012.41.6644

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Towards understanding the peripheral T-cell lymphomas.

Authors:  J O Armitage; J M Vose; D D Weisenburger
Journal:  Ann Oncol       Date:  2004-10       Impact factor: 32.976

Review 2.  Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.

Authors:  J Rodríguez; A Gutiérrez; B Martínez-Delgado; G Perez-Manga
Journal:  Crit Rev Oncol Hematol       Date:  2008-12-03       Impact factor: 6.312

Review 3.  Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).

Authors:  Claire E Dearden; Rod Johnson; Ruth Pettengell; Stephen Devereux; Kate Cwynarski; Sean Whittaker; Andrew McMillan
Journal:  Br J Haematol       Date:  2011-04-11       Impact factor: 6.998

4.  Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.

Authors:  Richard L Piekarz; Robin Frye; H Miles Prince; Mark H Kirschbaum; Jasmine Zain; Steven L Allen; Elaine S Jaffe; Alexander Ling; Maria Turner; Cody J Peer; William D Figg; Seth M Steinberg; Sonali Smith; David Joske; Ian Lewis; Laura Hutchins; Michael Craig; A Tito Fojo; John J Wright; Susan E Bates
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

5.  Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.

Authors:  R L Piekarz; R Robey; V Sandor; S Bakke; W H Wilson; L Dahmoush; D M Kingma; M L Turner; R Altemus; S E Bates
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.

Authors:  Marcel W Bekkenk; Maarten H Vermeer; Patty M Jansen; Ariënne M W van Marion; Marijke R Canninga-van Dijk; Philip M Kluin; Marie-Louise Geerts; Chris J L M Meijer; Rein Willemze
Journal:  Blood       Date:  2003-05-15       Impact factor: 22.113

7.  Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

Authors:  C Gisselbrecht; P Gaulard; E Lepage; B Coiffier; J Brière; C Haioun; D Cazals-Hatem; A Bosly; L Xerri; H Tilly; F Berger; R Bouhabdallah; J Diebold
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

Review 8.  Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review.

Authors:  Delvys Rodriguez-Abreu; Volmar Belisario Filho; Emanuele Zucca
Journal:  Hematol Oncol       Date:  2008-03       Impact factor: 5.271
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.